MRSA Hideaki Hanaki 1 1Kitasato Institute for Life Science and Laboratory for Antimicrobial Agents, Kitasato University Keyword: バンコマイシン , テイコプラニン , アルベカシン , リネゾリド , ダプトマイシン pp.844-849
Published Date 2012/8/15
DOI https://doi.org/10.11477/mf.1542103094
  • Abstract
  • Look Inside
  • Reference

MRSA (methicillin-resistant Staphylococcus aureus) is one of bacteria known to have a high ability to adapt to harsh conditions, which is shown by its acquisition of antibiotic resistance. Despite efforts of scientists to synthesize more potent antibiotics during the last several decades, antibiotic resistance continues to evolve, mainly because of the misuse and overuse of antibiotics. MRSA is resistant to almost all commonly used antibiotics, and is likely to soon become resistant to newly developed antibiotics. The most effective solution to preserve the activity of the current antibiotic armamentarium would be improving the use of antibiotics. Appropriate antibiotic use includes selection of a target-spectrum antibiotic, combination therapy with different classes of antibiotics, as well as finding an appropriate duration and dose and determining the correct duration of its use.

Copyright © 2012, Igaku-Shoin Ltd. All rights reserved.


電子版ISSN 1882-1367 印刷版ISSN 0485-1420 医学書院